Cargando…
Current Overview of Treatment for Metastatic Bone Disease
The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications, including bone pain, pathological fractures, spinal cord or nerve root compression, and hypercalcemia. Befor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482272/ https://www.ncbi.nlm.nih.gov/pubmed/34590591 http://dx.doi.org/10.3390/curroncol28050290 |
_version_ | 1784576869184569344 |
---|---|
author | Tsukamoto, Shinji Kido, Akira Tanaka, Yasuhito Facchini, Giancarlo Peta, Giuliano Rossi, Giuseppe Mavrogenis, Andreas F. |
author_facet | Tsukamoto, Shinji Kido, Akira Tanaka, Yasuhito Facchini, Giancarlo Peta, Giuliano Rossi, Giuseppe Mavrogenis, Andreas F. |
author_sort | Tsukamoto, Shinji |
collection | PubMed |
description | The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications, including bone pain, pathological fractures, spinal cord or nerve root compression, and hypercalcemia. Before initiation of treatment for bone metastasis, it is important to exclude primary bone malignancy, which would require a completely different therapeutic approach. It is essential to select surgical methods considering the patient’s prognosis, quality of life, postoperative function, and risk of postoperative complications. Therefore, bone metastasis treatment requires a multidisciplinary team approach, including radiologists, oncologists, and orthopedic surgeons. Recently, many novel palliative treatment options have emerged for bone metastases, such as stereotactic body radiation therapy, radiopharmaceuticals, vertebroplasty, minimally invasive spine stabilization with percutaneous pedicle screws, acetabuloplasty, embolization, thermal ablation techniques, electrochemotherapy, and high-intensity focused ultrasound. These techniques are beneficial for patients who may not benefit from surgery or radiotherapy. |
format | Online Article Text |
id | pubmed-8482272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84822722021-10-01 Current Overview of Treatment for Metastatic Bone Disease Tsukamoto, Shinji Kido, Akira Tanaka, Yasuhito Facchini, Giancarlo Peta, Giuliano Rossi, Giuseppe Mavrogenis, Andreas F. Curr Oncol Review The number of patients with bone metastasis increases as medical management and surgery improve the overall survival of patients with cancer. Bone metastasis can cause skeletal complications, including bone pain, pathological fractures, spinal cord or nerve root compression, and hypercalcemia. Before initiation of treatment for bone metastasis, it is important to exclude primary bone malignancy, which would require a completely different therapeutic approach. It is essential to select surgical methods considering the patient’s prognosis, quality of life, postoperative function, and risk of postoperative complications. Therefore, bone metastasis treatment requires a multidisciplinary team approach, including radiologists, oncologists, and orthopedic surgeons. Recently, many novel palliative treatment options have emerged for bone metastases, such as stereotactic body radiation therapy, radiopharmaceuticals, vertebroplasty, minimally invasive spine stabilization with percutaneous pedicle screws, acetabuloplasty, embolization, thermal ablation techniques, electrochemotherapy, and high-intensity focused ultrasound. These techniques are beneficial for patients who may not benefit from surgery or radiotherapy. MDPI 2021-08-29 /pmc/articles/PMC8482272/ /pubmed/34590591 http://dx.doi.org/10.3390/curroncol28050290 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tsukamoto, Shinji Kido, Akira Tanaka, Yasuhito Facchini, Giancarlo Peta, Giuliano Rossi, Giuseppe Mavrogenis, Andreas F. Current Overview of Treatment for Metastatic Bone Disease |
title | Current Overview of Treatment for Metastatic Bone Disease |
title_full | Current Overview of Treatment for Metastatic Bone Disease |
title_fullStr | Current Overview of Treatment for Metastatic Bone Disease |
title_full_unstemmed | Current Overview of Treatment for Metastatic Bone Disease |
title_short | Current Overview of Treatment for Metastatic Bone Disease |
title_sort | current overview of treatment for metastatic bone disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482272/ https://www.ncbi.nlm.nih.gov/pubmed/34590591 http://dx.doi.org/10.3390/curroncol28050290 |
work_keys_str_mv | AT tsukamotoshinji currentoverviewoftreatmentformetastaticbonedisease AT kidoakira currentoverviewoftreatmentformetastaticbonedisease AT tanakayasuhito currentoverviewoftreatmentformetastaticbonedisease AT facchinigiancarlo currentoverviewoftreatmentformetastaticbonedisease AT petagiuliano currentoverviewoftreatmentformetastaticbonedisease AT rossigiuseppe currentoverviewoftreatmentformetastaticbonedisease AT mavrogenisandreasf currentoverviewoftreatmentformetastaticbonedisease |